J&J Will Have Up to 800 Million COVID-19 Vaccines Available by Early 2021: CFO

J&J Will Have Up to 800 Million COVID-19 Vaccines Available by Early 2021: CFO
A researcher works at a Johnson & Johnson research facility, in Val-de-Reuil, northwestern France, on Nov. 30, 2017. Charly Triballeau/AFP via Getty Images
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:

Johnson & Johnson expects to have up to 800 million vaccines available by early next year for the COVID-19 disease, one of the strongest projections from a company involved in researching the vaccines.

No vaccines currently exist for COVID-19, which is caused by the CCP (Chinese Communist Party) virus, a new coronavirus that emerged from mainland China last year. There are no proven treatments either, though some have shown promise.
Google LogoMark Us Preferred on Google
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics